TUSA, IGNAZIA
 Distribuzione geografica
Continente #
EU - Europa 1.374
NA - Nord America 1.283
AS - Asia 209
AF - Africa 1
Totale 2.867
Nazione #
US - Stati Uniti d'America 1.269
PL - Polonia 818
IT - Italia 233
IE - Irlanda 136
SE - Svezia 89
HK - Hong Kong 77
CN - Cina 52
JO - Giordania 33
GB - Regno Unito 23
DE - Germania 20
VN - Vietnam 20
FI - Finlandia 15
RU - Federazione Russa 15
CA - Canada 14
SG - Singapore 12
BE - Belgio 9
IN - India 6
CH - Svizzera 5
ID - Indonesia 3
FR - Francia 2
JP - Giappone 2
NL - Olanda 2
PH - Filippine 2
TW - Taiwan 2
UA - Ucraina 2
AT - Austria 1
BY - Bielorussia 1
ES - Italia 1
LY - Libia 1
PT - Portogallo 1
RO - Romania 1
Totale 2.867
Città #
Warsaw 818
Fairfield 180
Chandler 152
Dublin 131
Ashburn 105
Florence 102
Seattle 96
Woodbridge 88
Cambridge 75
Ann Arbor 65
Houston 65
Wilmington 61
Hong Kong 52
Lawrence 43
Altamura 42
Princeton 31
Beijing 23
Boston 23
Buffalo 23
San Diego 19
Dong Ket 16
Moscow 15
Shanghai 15
Kent 14
Ottawa 12
Singapore 12
Boardman 10
Rome 10
Brussels 9
London 6
Medford 6
Prato 6
Bern 5
Phoenix 5
Pune 5
Renton 5
Turin 5
Cagliari 4
Guangzhou 4
Andover 3
Detroit 3
Falls Church 3
Liverpool 3
Malang 3
Menlo Park 3
Milan 3
Norwalk 3
Anghiari 2
Castelliri 2
Foggia 2
Kaohsiung City 2
Karlskrona 2
Karlsruhe 2
Munich 2
Redwood City 2
Rubano 2
San Juan 2
Siena 2
Silea 2
Toronto 2
Trumbull 2
West Jordan 2
Acireale 1
Atlanta 1
Austin 1
Baotou 1
Bologna 1
Bremen 1
Busto Arsizio 1
Castel Volturno 1
Certaldo 1
Chennai 1
Costa Mesa 1
Cuneo 1
Dearborn 1
Fremont 1
Fuente Del Maestre 1
Gunzenhausen 1
Heidelberg 1
Helsinki 1
Hillsboro 1
Hrodna 1
Jacksonville 1
Krefeld 1
Lappeenranta 1
Laurel 1
Leipzig 1
Nanjing 1
Nuremberg 1
Perugia 1
Prescot 1
Redmond 1
Rotterdam 1
Santa Clara 1
Scarperia 1
Stevenage 1
Tombolo 1
Tripoli 1
Udine 1
Urlati 1
Totale 2.450
Nome #
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 246
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 233
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 232
ERK5 is activated by oncogenic BRAF and promotes melanoma growth 219
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 198
Role of ERK5/BMK1 in the survival, proliferation and stemness of chronic myeloid leukemia cells in hypoxia 196
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 180
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 161
Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway 124
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy 113
AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia 109
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 94
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 77
Non-thermal effects of 2.45 GHz microwaves on spindle assembly, mitotic cells and viability of Chinese hamster V-79 cells 68
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 68
Hepatocyte-specific deletion of HIF2α prevents NASH-related liver carcinogenesis by decreasing cancer cell proliferation 58
Inhibition of ERK5 elicits cellular senescence in melanoma via the cyclin-dependent kinase inhibitor p21 56
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 54
Spontaneous and bleomycin-induced chromosome damage in non cancer thyroid patients. 51
Playing the Whack-A-Mole Game: ERK5 Activation Emerges Among the Resistance Mechanisms to RAF-MEK1/2-ERK1/2- Targeted Therapy 50
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL 46
The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells 44
Lactate maintainsBCR/Abl expression and signalinginChronic Myeloid Leukemia cells under nutrient restriction 44
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 43
Anti-β4 integrin autoantibodies in patients with mucous membrane pemphigoid: a retrospective analysis from a tertiary centre in Italy 41
ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS 39
ERK5 inhibition elicits cellular senescence in human melanoma cells 38
Positive correlation of HIF2α and SERPINB3 in human hepatocellular carcinoma: selectivity and prognostic implications 30
Targeting MAPK in Cancer 2.0 16
Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress 15
Sphingosine 1-phosphate elicits a ROS-mediated proinflammatory response in human endometrial stromal cells via ERK5 activation 12
Latent-transforming growth factor β-binding protein 1/Transforming growth factor β1 complex drives antitumoral effects upon ERK5 targeting in melanoma 5
Totale 2.960
Categoria #
all - tutte 8.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.546


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201955 0 0 0 0 0 0 0 0 0 0 0 55
2019/2020617 30 60 32 43 73 57 63 84 59 47 57 12
2020/2021439 32 58 8 62 22 38 26 28 48 70 24 23
2021/2022318 32 15 23 20 17 10 25 14 36 23 42 61
2022/2023676 52 117 44 28 53 110 88 56 90 9 13 16
2023/2024295 12 22 32 14 14 37 21 84 9 18 32 0
Totale 2.960